Chargement en cours...
Immunotherapeutic options for Epstein–Barr virus-associated lymphoproliferative disease following transplantation
Epstein–Barr virus-associated lymphoproliferative diseases (EBV-LPD) after hematopoietic stem cell transplantation or solid-organ transplantation remain a serious and potentially life-threatening complication. In the last decade, outcomes for EBV-LPD have significantly improved. Key to this success...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3075565/ https://ncbi.nlm.nih.gov/pubmed/20874650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.10.43 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|